Abstract:PURPOSE: To study the epidemiology of oral candidiasis and the effect of treatment of thrush in human immunodeficiency virus (HIV)-infected patients.PATIENTS AND METHODS: We conducted a prospective observational study of 92 patients over 1 year, including a nonblinded, randomized treatment trial of thrush with clotrimazole troches or oral fluconazole. Oral sites were cultured monthly and when thrush occurred. Candida albicans strains were typed by contour-clamped homogeneous electric field (CHEF) electrophoresis. Changes in strains were evaluated over time and in regard to their associations with particular sites, episodes of thrush, relapse after treatment, and colonization of sexual partners. Susceptibility to fluconazole was tested and CHEF analysis was done on these strains to determine the epidemiology of fluconazole resistance.RESULTS: Yeasts colonized 84% of patients. C albicans accounted for 81% of all isolates and was separated into 34 distinct strains. Most patients had persistent carriage of 1 or 2 dominant strains of C albicans. Three couples shared strains. Nineteen different C albicans strains caused 82 episodes of thrush in 45 patients. CD4 <200/mu L was associated with development of thrush. Clinical cure rates were similar with fluconazole (96%) and clotrimazole (91%), but mycologic cure was better with fluconazole (49%) than clotrimazole (27%). Following mycologic cure, colonization recurred with the same strain 74% of the time.Colonization with Torulopsis glabrata and Saccharomyces cerevisiae increased after treatment with either drug, but these organisms were never a sole cause of thrush. In a subset of 35 patients followed for over 3 months in whom fluconazole susceptibilities were performed, minimum inhibitory concentrations (MICs) to fluconazole increased only in those on fluconazole prophylaxis. Clinical failure of fluconazole was associated with an MIC greater than or equal to 64 mu g/mL in 3 patients, and with an MIC of 8 mu g/mL in 1 patient. In 2 of these 4 patients, the prior colonizing strain developed fluconazole resistance. In the other 2, new resistant strains were acquired.CONCLUSIONS: Many different strains of C albicans colonize and cause thrush in patients infected with HIV. Patients are usually persistently colonized with a single strain, and recurrences following treatment are usually due to the same strain. Transmission of strains may occur between couples. Fluconazole and clotrimazole are equally effective in treating thrush, but mycologic cure occurs more often with fluconazole.Fluconazole resistance in C albicans occurs most often in patients who have low CD4 counts and are taking fluconazole prophylactically for recurrent thrush. Fluconazole resistance may occur through acquisition of a new resistant strain or by development of resistance in a previously susceptible strain.

Influence of Prophylactic Application of Fluconazole on Antifungal Susceptibility to Strains of Candida Isolated from the Patients with High Risk of Deep Fungal Infections

Posaconazole Vs. Fluconazole As Invasive Fungal Infection Prophylaxis in China: A Multicenter, Randomized, Open-Label Study

Effectiveness analysis of fluconazole prophylaxis of fungus infection in patients with hematological diseases

Analysis of antifungal susceptibility in vitro and fungi distribution in clinics

Invasive Candidiasis in Intensive Care Units in China: in Vitro Antifungal Susceptibility in the China-SCAN Study

Species distribution and antifungal susceptibility of Candida sp. isolates from AIDS patients with oropharyngeal candidiasis

Antifungal Susceptibility Testing of Commensal and Pathogenic Clinical Isolates of Oral Candida

Susceptibility of non-Candida albicans isolates to common antifungal agents

In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.

Surveillance of resistance to fluconazole and voriconazole in Candida isolates from 5 hospitals in China

[Candida Species Distribution in the Patients with High Risk of Deep Fungal Infections and Relevant Risk Factors: a Prospective Cohort Study].

Epidemiology of Oral Candidiasis in HIV-infected Patients: Colonization, Infection, Treatment, and Emergence of Fluconazole Resistance

Analysis of Resistance and Sensitivity of 1 200 Strains of Vulvovaginal Candidiasis in China to Five Common Antifungal Drugs

Assaying the Susceptibility of Fluconazole-Resistant Candida Albicans to Common Antifungal Drugs

The study on inducing fluconazole resistance in Candida albicans and the stability of induced resistance

Evaluation of Biofilm Production and Antifungal Susceptibility to Fluconazole in Clinical Isolates of Candida spp. in Both Planktonic and Biofilm Form

Correlation Between Drug Resistance and Virulence of Candida Isolates from Patients with Candidiasis

The separation and identification of clinical deep fungus and the analysis of drug susceptibility results

Prevalence and Resistance Characteristics of Fungal Infection in Intensive Care Unit

Synergistic potential of teriflunomide with fluconazole against resistant Candida albicans in vitro and in vivo

Antifungal Susceptibility Testing of 100 Clinical Isolates of Pathogenic Yeasts